Listening to consumers and HIV vaccine preparedness

Lancet

Volumn 365, Issue 9465, 2005, Pages 1119-1121

  Duan, Naihua ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AWARENESS; CONSUMER; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; HEALTH CARE SYSTEM; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MASS MEDIUM; NOTE; PRIORITY JOURNAL; SOCIAL PROBLEM; SOCIAL PSYCHOLOGY;

EID: 15744401962     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)71857-2     Document Type: Note

References (18)

1. E Mills, C Cooper, G Guyatt Barriers to participating in an HIV vaccine trial: a systematic review AIDS 18 2004 2235 2242
2. GL Urban, JR Hauser Design and marketing of new products 2nd edn. 1993 Prentice Hall Englewood Cliffs, New Jersey
3. AR Andreasen Marketing social change: changing behavior to promote health, social development, and the environment 1995 Jossey-Bass San Francisco
4. PA Newman, N Duan, ET Rudy, PA Anton Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come? AIDS Patient Care STD 18 2004 691 701
5. F Dubois-Arber, P Lehmann, D Hausser Towards improved action against AIDS World Health Forum 9 1988 376 381
6. F Dubois-Arber, A Jeannin, E Konings, F Paccaud Increased condom use without other major changes in sexual behavior among the general population in Switzerland Am J Public Health 87 1997 558 566
7. F Dubois-Arber, A Jeannin, B Spencer Long term global evaluation of a national AIDS prevention strategy: the case of Switzerland AIDS 13 1999 2571 2582
8. GJ Nowak, MJ Siska Using research to inform campaign development and message design E Maibach RL Parrott Designing health messages 1995 Sage Publications Newbury Park, California 169 185
9. DR Woods, D Davis, BJ Westover "America Responds to AIDS": its content, development process, and outcome Public Health Rep 106 1991 616 622
10. J Esparza, S Osmanov, C Pattou-Markovic, C Toure, ML Chang, S Nixon Past, present and future of HIV vaccine trials in developing countries Vaccine 20 2002 1897 1898
11. P Streefland Introduction of a HIV vaccine in developing countries: social and cultural dimensions Vaccine 21 2003 1304 1309
12. DP Francis, WL Heyward, V Popovic Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials AIDS 17 2003 147 156
13. SP Buchbinder, B Metch, SE Holte, S Scheer, A Coletti, E Vittinghoff Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation J Acquir Immune Defic Syndr 36 2004 604 612
14. DD Celentano, C Beyrer, C Natpratan Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand AIDS 9 1995 1079 1083
15. T Tucker, C Slack Not if but how? Caring for HIV-1 vaccine trial participants in South Africa Lancet 362 2003 995
16. ML Chang, C Vitek, J Esparza WHO-UNAIDS-CDC Public health considerations for the use of a first generation HIV vaccine: report from a WHO-UNAIDS-CDC consultation, Geneva, 20-21 November 2002 AIDS 17 2003 W1 W10
17. P Newman, N Duan, E Rudy, K Johnston-Roberts, D Swendeman Post-efficacy-trial HIV vaccine adoption: concerns, motivators and intentions among persons at risk for HIV J Acquir Immune Defic Syndr 37 2004 1393 1403
18. GD Zimet, D Fortenberry, MB Blythe Adolescents' attitudes about HIV immunization J Pediatric Psychol 24 1999 67 75